Expeditors Reports Q4 Earnings, Beats Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy EXPD?
Source: seekingalpha
Expeditors International's stock fell 5.10% as it hit a 5-day low amid broader market gains, with the Nasdaq-100 up 0.41% and S&P 500 up 0.17%.
The company reported a Q4 GAAP EPS of $1.49, exceeding expectations by $0.03, despite a slight revenue decline of 3.1% year-over-year to $2.86 billion. This performance indicates resilience amidst market challenges, although the overall profitability is under pressure due to a weak ocean freight environment. Additionally, Expeditors announced a $3 billion stock buyback plan aimed at enhancing shareholder value, reflecting confidence in future growth prospects.
The implications of these results suggest that while Expeditors is navigating a tough logistics environment, its ability to exceed earnings expectations and implement a significant buyback program may attract investor interest and support its stock price in the long term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EXPD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EXPD
Wall Street analysts forecast EXPD stock price to fall
10 Analyst Rating
2 Buy
4 Hold
4 Sell
Hold
Current: 147.240
Low
95.00
Averages
141.11
High
179.00
Current: 147.240
Low
95.00
Averages
141.11
High
179.00
About EXPD
Expeditors International of Washington, Inc. is a global logistics company. The Company’s services include consolidation or forwarding of air and ocean freight, customs brokerage, vendor consolidation, cargo insurance, time-definite transportation, order management, warehousing and distribution and customized logistics solutions. The Company’s primary services include airfreight services, ocean freight and ocean services, and customs brokerage and other services. It provides a full suite of global logistics services, offering customers access to an international network of people and integrated information systems to support the movement and strategic positioning of goods. As a third-party logistics provider, it purchases cargo space from carriers on a volume basis and resells that space to its customers. In addition, its Project Cargo unit handles special project shipments that move via a single method or combination of air, ocean, and/or ground transportation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Iran War Disrupts European Semiconductor Imports
- Rising Transportation Costs: The Iran war has disrupted air freight routes in the Middle East, causing European companies to face increased shipping costs, with global air freight capacity down approximately 9% compared to pre-war levels, forcing firms to pay higher rates to ensure timely deliveries.
- Delivery Delays: Some European semiconductor companies and automotive manufacturers are experiencing delivery delays, with reports of a few days' lag in shipments; while overall import volumes have not significantly dropped, many buyers are paying premiums to maintain supply chain stability.
- Inventory Management Strategies: Under pressure from high shipping costs, buyers of lower-value goods are more likely to dip into inventory, while importers of high-value products absorb these costs to ensure continuity in their supply chains, highlighting the sensitivity of different product categories to transportation expenses.
- Supply Chain Stress Testing: Companies are actively responding to disruptions in critical transport routes, particularly the Strait of Hormuz and Dubai airport, leading to depleted buffer inventory levels and increased logistics costs, necessitating real-time assessments of supplier risks and inventory rebalancing.
See More
Trump Tariff Refund Legal Battle Intensifies
- Legal Deadline Approaches: The U.S. Court of International Trade has set a deadline for the DOJ to respond by April 24 regarding tariff refund cases, with over 2,000 lawsuits filed by companies seeking refunds, potentially impacting up to $175 billion, highlighting the urgency and complexity of the government's handling of tariff issues.
- Impact on Refund Process: Plaintiff V.O.S. is urging the court to expedite its refund request, and the court's prompt action could serve as a template for other similar cases, indicating that this case may become a critical reference for future tariff refunds, affecting the financial health of numerous small businesses.
- Increased Political Pressure: Democrats are pressuring the Trump administration to formulate a refund plan, with the Treasury Secretary stating that payouts could take years, reflecting the government's struggle between legal challenges and public expectations, which may impact its political image.
- Legal Expert Insights: Legal experts note that while the Supreme Court did not directly rule on the refund process, it has made it clear that importers who paid unlawful tariffs are entitled to refunds, emphasizing the necessity and legality of the refund process, which could lead to further legal challenges for the government.
See More
Analysis and Outlook: Exploring Claude Nine
- Market Recovery: Stocks made a significant recovery on Tuesday, nearly offsetting the losses experienced on Monday.
- Investor Sentiment: The rebound indicates a shift in investor sentiment following a period of decline.
- Economic Indicators: The recovery may be influenced by various economic indicators that are being closely monitored by analysts.
- Future Outlook: Analysts are assessing whether this trend will continue or if further volatility is expected in the market.
See More
US Stocks Rebound Led by Software and Chipmakers
- Market Rebound: The S&P 500 Index rose by 0.77%, the Dow Jones Industrial Average increased by 0.76%, and the Nasdaq 100 Index climbed by 1.09%, indicating a recovery after Monday's sharp declines, reflecting investor optimism regarding economic data.
- Software and Chip Stocks Surge: Following AI startup Anthropic PBC's emphasis on partnerships, software and chip manufacturers saw significant stock price increases, indicating growing market confidence in the integration of AI technologies, which could enhance their competitive positioning.
- Consumer Confidence Boost: The US February consumer confidence index rose by 2.2 to 91.2, surpassing expectations of 87.1, suggesting increased consumer optimism about the economic outlook, which may lead to higher consumer spending and positively impact economic growth.
- Interest Rates and Economic Data Focus: The market is discounting only a 2% chance of a rate cut at the Fed's March 17-18 meeting, indicating cautious investor sentiment regarding future monetary policy, while closely monitoring upcoming corporate earnings and economic data releases.
See More
U.S. Markets Rose on Tuesday, with Keysight Technologies Driving Gains
- U.S. Stock Market Performance: U.S. stock indexes experienced gains on Tuesday, with the S&P 500 rising by 1.04%.
- Index Movements: The Dow Jones Industrial Average increased by 0.77%, while the Nasdaq Composite saw a rise of 0.76%.
See More
Analysis of Stock Price Movements for Multiple Companies
- Dillard's Revenue Decline: Dillard's reported fourth-quarter revenue of $1.99 billion, falling short of the $2.03 billion expected by analysts, leading to a 7% drop in shares, primarily due to winter storms impacting over a third of its stores, highlighting the significant effect of seasonal weather on retail performance.
- Planet Fitness Weak Guidance: Planet Fitness anticipates full-year adjusted earnings per share growth of only 9% to 10%, well below the 16.5% expected by analysts, resulting in an 8% decline in shares, reflecting market concerns over its future growth potential.
- Novo Nordisk Price Reduction Strategy: Novo Nordisk announced it would cut monthly list prices for Wegovy and Ozempic by up to 50%, causing a 2% drop in shares, which may impact its market share and profit margins amid increasing competition.
- Vir Biotechnology Stock Surge: Vir Biotechnology's shares surged nearly 30% following positive Phase 1 results for its VIR-5500 treatment for metastatic prostate cancer, indicating strong potential for its research and an increase in market confidence.
See More
Iran War Disrupts European Semiconductor Imports
- Rising Transportation Costs: The Iran war has disrupted air freight routes in the Middle East, causing European companies to face increased shipping costs, with global air freight capacity down approximately 9% compared to pre-war levels, forcing firms to pay higher rates to ensure timely deliveries.
- Delivery Delays: Some European semiconductor companies and automotive manufacturers are experiencing delivery delays, with reports of a few days' lag in shipments; while overall import volumes have not significantly dropped, many buyers are paying premiums to maintain supply chain stability.
- Inventory Management Strategies: Under pressure from high shipping costs, buyers of lower-value goods are more likely to dip into inventory, while importers of high-value products absorb these costs to ensure continuity in their supply chains, highlighting the sensitivity of different product categories to transportation expenses.
- Supply Chain Stress Testing: Companies are actively responding to disruptions in critical transport routes, particularly the Strait of Hormuz and Dubai airport, leading to depleted buffer inventory levels and increased logistics costs, necessitating real-time assessments of supplier risks and inventory rebalancing.
See More
Trump Tariff Refund Legal Battle Intensifies
- Legal Deadline Approaches: The U.S. Court of International Trade has set a deadline for the DOJ to respond by April 24 regarding tariff refund cases, with over 2,000 lawsuits filed by companies seeking refunds, potentially impacting up to $175 billion, highlighting the urgency and complexity of the government's handling of tariff issues.
- Impact on Refund Process: Plaintiff V.O.S. is urging the court to expedite its refund request, and the court's prompt action could serve as a template for other similar cases, indicating that this case may become a critical reference for future tariff refunds, affecting the financial health of numerous small businesses.
- Increased Political Pressure: Democrats are pressuring the Trump administration to formulate a refund plan, with the Treasury Secretary stating that payouts could take years, reflecting the government's struggle between legal challenges and public expectations, which may impact its political image.
- Legal Expert Insights: Legal experts note that while the Supreme Court did not directly rule on the refund process, it has made it clear that importers who paid unlawful tariffs are entitled to refunds, emphasizing the necessity and legality of the refund process, which could lead to further legal challenges for the government.
See More
Analysis and Outlook: Exploring Claude Nine
- Market Recovery: Stocks made a significant recovery on Tuesday, nearly offsetting the losses experienced on Monday.
- Investor Sentiment: The rebound indicates a shift in investor sentiment following a period of decline.
- Economic Indicators: The recovery may be influenced by various economic indicators that are being closely monitored by analysts.
- Future Outlook: Analysts are assessing whether this trend will continue or if further volatility is expected in the market.
See More
US Stocks Rebound Led by Software and Chipmakers
- Market Rebound: The S&P 500 Index rose by 0.77%, the Dow Jones Industrial Average increased by 0.76%, and the Nasdaq 100 Index climbed by 1.09%, indicating a recovery after Monday's sharp declines, reflecting investor optimism regarding economic data.
- Software and Chip Stocks Surge: Following AI startup Anthropic PBC's emphasis on partnerships, software and chip manufacturers saw significant stock price increases, indicating growing market confidence in the integration of AI technologies, which could enhance their competitive positioning.
- Consumer Confidence Boost: The US February consumer confidence index rose by 2.2 to 91.2, surpassing expectations of 87.1, suggesting increased consumer optimism about the economic outlook, which may lead to higher consumer spending and positively impact economic growth.
- Interest Rates and Economic Data Focus: The market is discounting only a 2% chance of a rate cut at the Fed's March 17-18 meeting, indicating cautious investor sentiment regarding future monetary policy, while closely monitoring upcoming corporate earnings and economic data releases.
See More
U.S. Markets Rose on Tuesday, with Keysight Technologies Driving Gains
- U.S. Stock Market Performance: U.S. stock indexes experienced gains on Tuesday, with the S&P 500 rising by 1.04%.
- Index Movements: The Dow Jones Industrial Average increased by 0.77%, while the Nasdaq Composite saw a rise of 0.76%.
See More
Analysis of Stock Price Movements for Multiple Companies
- Dillard's Revenue Decline: Dillard's reported fourth-quarter revenue of $1.99 billion, falling short of the $2.03 billion expected by analysts, leading to a 7% drop in shares, primarily due to winter storms impacting over a third of its stores, highlighting the significant effect of seasonal weather on retail performance.
- Planet Fitness Weak Guidance: Planet Fitness anticipates full-year adjusted earnings per share growth of only 9% to 10%, well below the 16.5% expected by analysts, resulting in an 8% decline in shares, reflecting market concerns over its future growth potential.
- Novo Nordisk Price Reduction Strategy: Novo Nordisk announced it would cut monthly list prices for Wegovy and Ozempic by up to 50%, causing a 2% drop in shares, which may impact its market share and profit margins amid increasing competition.
- Vir Biotechnology Stock Surge: Vir Biotechnology's shares surged nearly 30% following positive Phase 1 results for its VIR-5500 treatment for metastatic prostate cancer, indicating strong potential for its research and an increase in market confidence.
See More
